| TGF‐β signalling and liver disease I Fabregat, J Moreno‐Càceres, A Sánchez, S Dooley, B Dewidar, ... The FEBS journal 283 (12), 2219-2232, 2016 | 616 | 2016 |
| TGF-β in hepatic stellate cell activation and liver fibrogenesis—updated 2019 B Dewidar, C Meyer, S Dooley, N Meindl-Beinker Cells 8 (11), 1419, 2019 | 605 | 2019 |
| Metabolic liver disease in diabetes–from mechanisms to clinical trials B Dewidar, S Kahl, K Pafili, M Roden Metabolism 111, 154299, 2020 | 133 | 2020 |
| TGF-β in hepatic stellate cell activation and liver fibrogenesis: updated B Dewidar, J Soukupova, I Fabregat, S Dooley Current pathobiology reports 3, 291-305, 2015 | 48 | 2015 |
| Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance ZC Nwosu, W Piorońska, N Battello, AD Zimmer, B Dewidar, M Han, ... EBioMedicine 54, 2020 | 45 | 2020 |
| TGF-β2 silencing to target biliary-derived liver diseases A Dropmann, S Dooley, B Dewidar, S Hammad, T Dediulia, J Werle, ... Gut 69 (9), 1677-1690, 2020 | 38 | 2020 |
| Impaired hepatic mitochondrial capacity in nonalcoholic steatohepatitis associated with type 2 diabetes S Gancheva, S Kahl, D Pesta, L Mastrototaro, B Dewidar, K Strassburger, ... Diabetes Care 45 (4), 928-937, 2022 | 33 | 2022 |
| Delta-like ligand 4 modulates liver damage by down-regulating chemokine expression Z Shen, Y Liu, B Dewidar, J Hu, O Park, T Feng, C Xu, C Yu, Q Li, C Meyer, ... The American Journal of Pathology 186 (7), 1874-1889, 2016 | 33 | 2016 |
| Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation S Hammad, A Othman, C Meyer, A Telfah, J Lambert, B Dewidar, J Werle, ... Archives of toxicology 92, 2549-2561, 2018 | 29 | 2018 |
| Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease K Pafili, S Kahl, L Mastrototaro, K Strassburger, D Pesta, C Herder, ... Journal of Hepatology 77 (6), 1504-1514, 2022 | 26 | 2022 |
| TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019; 8 (11): 1419 B Dewidar, C Meyer, S Dooley, AN Meindl-Beinker | 16 | |
| Expression of TLR-2 in hepatocellular carcinoma is associated with tumour proliferation, angiogenesis and Caspase-3 expression FEZA Mohamed, S Hammad, TV Luong, B Dewidar, R Al-Jehani, ... Pathology-Research and Practice 216 (8), 152980, 2020 | 14 | 2020 |
| Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases B Dewidar, L Mastrototaro, C Englisch, C Ress, C Granata, E Rohbeck, ... EBioMedicine 94, 2023 | 11 | 2023 |
| Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice V Hartwig, B Dewidar, T Lin, A Dropmann, C Ganss, MA Kluth, ... Archives of Toxicology 93, 2645-2660, 2019 | 10 | 2019 |
| Histamine protects against the acute phase of experimentally-induced hepatic ischemia/re-perfusion NA El-Mahdy, AE El-Sisi, BI Dewidar, KI El-Desouky Journal of Immunotoxicology 10 (1), 9-16, 2013 | 9 | 2013 |
| Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression Y Zhang, DK Kim, Y Lu, YS Jung, J Lee, YH Kim, YS Lee, J Kim, ... PloS one 12 (7), e0182141, 2017 | 5 | 2017 |
| Dietary lipid droplet structure in postnatal life improves hepatic energy and lipid metabolism in a mouse model for postnatal programming T Jelenik, A Kodde, D Pesta, E Phielix, A Oosting, E Rohbeck, B Dewidar, ... Pharmacological research 179, 106193, 2022 | 3 | 2022 |
| Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease T Sarabhai, S Kahl, S Gancheva, L Mastrototaro, B Dewidar, D Pesta, ... Metabolism 151, 155762, 2024 | 2 | 2024 |
| 1212-P: adipose tissue mitochondrial function in humans with varying liver histology K Pafili, S Kahl, D Pesta, K Strassburger, L Mastrototaro, ... Diabetes 70 (Supplement_1), 2021 | 2 | 2021 |
| 293-OR: Improvement of Tissue-Specific Insulin Sensitivity after Bariatric Surgery Does Not Restore Hepatic OXPHOS Capacity S KAHL, J PUETZER-FURMANCZAK, N TRINKS, B DEWIDAR, K PAFILI, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
